Abstract
The discovery of a series of structurally-novel biaryl urea IDO inhibitors is described. Optimization of a micromolar hit through iterative cycles of synthesis and screening in an assay measuring IDO-mediated intracellular conversion of tryptophan to kynurenine led to potent inhibitors with favorable selectivity and metabolic stability profiles.
Keywords:
IDO; Immuno-oncology; Indoleamine 2,3-dioxygenase; Kynurenine.
Copyright © 2016 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Carboxylic Acids / chemical synthesis
-
Carboxylic Acids / chemistry
-
Carboxylic Acids / pharmacology*
-
Dogs
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
HeLa Cells
-
High-Throughput Screening Assays
-
Humans
-
Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors*
-
Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism
-
Mice
-
Microsomes, Liver / chemistry
-
Microsomes, Liver / metabolism
-
Molecular Structure
-
Structure-Activity Relationship
-
Urea / analogs & derivatives
-
Urea / chemistry
-
Urea / pharmacology*
Substances
-
Carboxylic Acids
-
Enzyme Inhibitors
-
Indoleamine-Pyrrole 2,3,-Dioxygenase
-
Urea